Search results for "harm"

showing 10 items of 13866 documents

Reducing the burden of Herpes Zoster in Italy.

2015

Herpes Zoster (HZ) is a viral disease with painful neuro-dermatologic manifestations. Incidence increases with age. In Italy, the estimated incidence is 6.3 cases/1000 person/year; hospital admissions are less than 2%, 69% in patients aged over 65 years. The most frequent complication of HZ is Post-Herpetic Neuralgia (PHN) characterized by metameric pain, allodynia, and hyperalgesia. In Italy 20.6% and 9.2% of HZ patients experience PHN after 3 and 6 months, respectively. Available antiviral and analgesic treatments are relatively unsatisfactory in reducing pain and length of the disease. Prevention has recently become possible with the live attenuated vaccine Oka/Merck. Clinical studies sh…

medicine.medical_specialtyPediatricsHerpes Zoster epidemiology burden prevention immunizationSettore MED/17 - Malattie InfettiveCost-Benefit AnalysisImmunologyNeuralgia PostherpeticDiseaseSettore MED/42 - Igiene Generale E ApplicataimmunizationHerpes ZosterHerpes Zoster; epidemiology; burden; prevention; immunizationburdenChickenpox VaccinepreventionEpidemiologymedicineHumansImmunology and AllergyChickenpox VaccinePharmacologyHerpes Zoster; burden; epidemiology; immunization; preventionbusiness.industryIncidenceIncidence (epidemiology)medicine.diseaseSurgeryVaccinationAllodyniaItalyNeuralgiaepidemiologyViral diseasemedicine.symptombusinessResearch Paper
researchProduct

[Adverse reactions to human papillomavirus vaccine in the Valencian Community (2007-2011)].

2014

Introduction: In 2009, two cases of seizures in adolescents following quadrivalent human papillomavirus vaccine (qHPV) administration generated important media attention, and adversely affected public trust in this vaccine. Our objectives were to describe suspected adverse reactions (SARs) reported to the Pharmacovigilance Centre in the Valencian Community (PCVC) after administration of HPV vaccine, and to compare reporting rates of syncope and seizures following this vaccine with those of other vaccines administered to girls aged 13–15 years. Materials and methods: Descriptive study of SARs reported following administration of this vaccine to the PCVC between 2007 and 2011. Results: The cl…

medicine.medical_specialtyPediatricsHuman papillomavirusTime FactorsAdolescentVirus del papiloma humanoVaccines AdministeredHuman papillomavirus vaccinePediatricsRJ1-570Valencian communitySyncopeReporting ratePharmacovigilanceHuman Papillomavirus Recombinant Vaccine Quadrivalent Types 6 11 16 18SeizuresManagement of Technology and InnovationPharmacovigilanceMedicineHumansRetrospective StudiesbiologyVacunabusiness.industryReacción adversaSyncope (genus)PharmacovigitanceTasa de notificaciónbiology.organism_classificationSurgeryVaccinationFarmacovigilanciaSpainFemalebusinessAdverse reactionsVaccineAnales de pediatria (Barcelona, Spain : 2003)
researchProduct

Evaluation of the quality of publications on randomized clinical trials using the Consolidated Standards of Reporting Trials (CONSORT) statement guid…

2011

The main reason for conducting a clinical trial (CT) is to test the effect of a drug or medical procedure to improve treatment of a disease. CTs contribute most when they are rigorously conducted and the results are published adequately. The aim of this study is to assess, using the CONSORT statement guidelines, the quality of reporting of completed CTs conducted at a tertiary hospital to determine which sections of the articles should be improved. CTs published between 2002 and 2008 were identified by searching the MEDLINE and Cochrane Library. Forty of 127 completed CTs were published. There was a marked increase in the number of articles and the quality of the journals that published the…

medicine.medical_specialtyPediatricsMedical procedureAlternative medicineMEDLINEGuidelines as TopicCochrane Librarylaw.inventionHospitals UniversityRandomized controlled triallawmedicineHumansPharmacology (medical)Randomized Controlled Trials as TopicPharmacologybusiness.industryConsolidated Standards of Reporting Trialsnervous system diseasesTest (assessment)Clinical trialSpainFamily medicineJournal Impact FactorPeriodicals as TopicbusinessJournal of clinical pharmacology
researchProduct

Luspatercept Response in ESA-NaïVe/RS+ Patients and RS- Patients with Low-Intermediate Risk Myelodysplastic Syndromes (MDS)

2016

Abstract Background: Management of anemia is a common therapeutic challenge in patients with myelodysplastic syndromes (MDS). Luspatercept (ACE-536), a fusion protein containing modified activin receptor type IIB, is being developed for treatment of anemia in lower-risk MDS. Luspatercept binds GDF11 and other TGF-β superfamily ligands to promote late-stage erythroid differentiation and increase hemoglobin (Hgb) levels (Suragani R, Nat Med, 2014 and Attie K, Am J Hematol, 2014). Aims: This is an ongoing, phase 2, multicenter, open-label study to evaluate the effects of luspatercept in patient (pts) with low-intermediate risk MDS. Endpoints included erythroid response (IWG HI-E), RBC transfus…

medicine.medical_specialtyPediatricsbusiness.industryAnemiaMyelodysplastic syndromesImmunologyPhases of clinical researchCell BiologyHematologymedicine.diseaseBiochemistryGastroenterologyhemic and lymphatic diseasesPharmacodynamicsInternal medicineLuspaterceptCohortmedicineIntermediate riskbusinessLenalidomidemedicine.drugBlood
researchProduct

Pantoprazole: from drug metabolism to clinical relevance.

2008

Conditions requiring inhibition of acid secretion, such as gastro-oesophageal reflux disease (GORD), peptic ulcers, non-ulcer dyspepsia or the use of NSAIDs, are very common, and their prevalence is expecting to rise as they are seen predominantly amongst the elderly. Among the drugs available to inhibit acid secretion, proton pump inhibitors (PPI) have been shown to have the best efficacy-safety ratio and have been used widely.This paper was intended to provide an overall presentation of one of these PPIs, pantoprazole.This study was first intended to give an overview of pantoprazole, so a Medline search was conducted using pantoprazole as unique search term, without publication date restr…

medicine.medical_specialtyPeptic UlcerPepticRabeprazoleLansoprazoleToxicologyGastroenterology2-PyridinylmethylsulfinylbenzimidazolesEsomeprazoleInternal medicinemedicineHumansPantoprazoleOmeprazolePantoprazolePharmacologyClinical Trials as Topicbiologybusiness.industryProton Pump InhibitorsGeneral MedicineHelicobacter pyloribiology.organism_classificationAnti-Ulcer Agentsdigestive system diseasesTreatment OutcomeGastroesophageal RefluxbusinessDrug metabolismmedicine.drugExpert opinion on drug metabolismtoxicology
researchProduct

Pharmacokinetic and clinical evaluation of esomeprazole and ASA for the prevention of gastroduodenal ulcers in cardiovascular patients.

2012

Low-dose aspirin (ASA, 75 - 325 mg/day) is widely used for the primary and secondary prevention of cardiovascular (CV) diseases. However, the value of primary prevention ASA is uncertain as the reduction in occlusive events needs to be weighed against the significant increase in major bleedings. Prevention with antisecretory drugs has been proposed to reduce the incidence of ASA-induced gastrointestinal (GI) bleedings, but non-adherence to gastro-protection is of concern, as it significantly increases the risk of upper GI adverse events. Beside patients and physicians education, one approach to overcome non-adherence is the development of fixed-dose combination.This review explores the resu…

medicine.medical_specialtyPeptic UlcerToxicologyGastroenterologyEsomeprazolePharmacokineticsInternal medicinemedicineHumansIn patientDrug InteractionsAdverse effectRandomized Controlled Trials as TopicPharmacologyAspirinAspirinbusiness.industryIncidence (epidemiology)EsomeprazoleGeneral MedicineAnti-Ulcer Agentsdigestive system diseasesGastroduodenal ulcerCardiovascular DiseasesbusinessClinical evaluationPlatelet Aggregation Inhibitorsmedicine.drugExpert opinion on drug metabolismtoxicology
researchProduct

Ultrasound-guided ablation for hepatocellular carcinoma: time for a reappraisal?

2015

Ultrasound-guided techniques play a key role in the clinical management of hepatocellular carcinoma. Among these, percutaneous ethanol injection (PEI) was the first technique to be proposed for the treatment of nodular-type hepatocellular carcinoma: the role of PEI was first discussed during the European Association for the Study of the Liver conference held in Barcelona in 2000, 15 years ago. Since then, other techniques have been introduced and radiofrequency ablation now represents the most widely used percutaneous technique. PEI and radiofrequency ablation are widely used in clinical practice. However, only scant progresses in the application of these techniques have been performed over…

medicine.medical_specialtyPercutaneousCarcinoma HepatocellularEthanolbusiness.industryRadiofrequency ablationmedicine.medical_treatmentLiver Neoplasmstechnology industry and agriculturemedicine.diseaseAblationUltrasound guidedSurgerylaw.inventionClinical PracticeOncologylawHepatocellular carcinomaCatheter AblationMedicineHumansPharmacology (medical)Percutaneous ethanol injectionbusinessUltrasonography InterventionalExpert review of anticancer therapy
researchProduct

Mechanical circulatory support. An expert opinion of the Association of Intensive Cardiac Care and the Association of Cardiovascular Interventions of…

2021

Mechanical circulatory support (MCS) methods are used in patients with both acute and chronic heart failure, who have exhausted other options for pharmacological or surgical treatments. The purpose of their use is to support, partially or completely, the failed ventricles and ensure adequate organ perfusion, which allows patients to restore full cardiovascular capacity, prolonging their life and effectively improving its quality. The three most popular devices include an intra-aortic balloon pump (IABP), percutaneous assist devices (including Impella, TandemHeart), and venoarterial extracorporeal membrane oxygenation (VA-ECMO). A multidisciplinary approach with the special participation of …

medicine.medical_specialtyPercutaneousmedicine.medical_treatmentShock CardiogenicPsychological interventionventilation and pharmacotherapyPercutaneous Coronary InterventionExtracorporeal membrane oxygenationHumansMedicineIntensive care medicineExpert TestimonyImpellaMechanical ventilationIntra-Aortic Balloon Pumpingbusiness.industryCardiogenic shockmechanical circulatory support-type and extensionmedicine.diseasehemodynamic and echocardiographic monitoringHeart failureConventional PCIindications and complicationsmultidisciplinary approachHeart-Assist DevicesPolandCardiology and Cardiovascular MedicinebusinessKardiologia Polska
researchProduct

Calcium Dependence of the Mechanical Response Evoked by Okadaic Acid in Smooth Muscle

1995

The effects of okadaic acid (OA), obtained from a culture of the marine dinoflagellate Prorocentrum Lima were studied on isolated strips of rat myometrium. The contractile response evoked by OA at 5, 10, and 20 μM in normal physiological solution was unaffected in the presence of tetrodotoxin (10 μM), indomethacin (3 μM), or a cocktail of antagonists which blocked muscarinic, adrenergic, histaminergic, serotonergic, and opioid receptors. Similarly, the response to OA was unaffected in the presence of nifedipine at a concentration (1 μM) which completely or highly blocked the response to KCl (60 mM), oxytocin (1 μM), or acetylcholine (100 μM). In a Ca 2+ -free 1 mM EGTA-containing solution, …

medicine.medical_specialtyPharmaceutical Sciencechemistry.chemical_elementIn Vitro TechniquesCalciumBiologyAnalytical ChemistryRats Sprague-Dawleychemistry.chemical_compoundEthers CyclicInternal medicineOkadaic AcidDrug DiscoveryMuscarinic acetylcholine receptormedicineAnimalsVanadatePharmacologyOrganic ChemistryMyometriumOkadaic acidRatsEGTAEndocrinologyComplementary and alternative medicinechemistryMyometriumMolecular MedicineCalciumFemalemedicine.symptomAcetylcholineMuscle ContractionMuscle contractionmedicine.drugPlanta Medica
researchProduct

Selective inhibition of calcium entry induced by benzylisoquinolines in rat smooth muscle.

1992

Abstract The mechanism of relaxant activity of six benzylisoquinolines was examined in order to determine the minimal structural requirements that enable these compounds to have either a non-specific action like papaverine or an inhibitory activity on calcium entry via potential-operated channels. All the alkaloids tested totally or partially relaxed KCl-depolarized rat uterus and inhibited oxytocin-induced rhythmic contractions. Only glaucine and laudanosine inhibited K+-induced uterine contractions more than oxytocin-induced uterine contractions. In Ca+-free medium, sustained contractions induced by oxytocin or vanadate were relaxed by the alkaloids tested except for glaucine and laudanos…

medicine.medical_specialtyPharmaceutical Sciencechemistry.chemical_elementPharmacologyCalciumIn Vitro TechniquesOxytocinCalcium in biologyUterine contractionLaudanosinechemistry.chemical_compoundUterine ContractionAlkaloidsInternal medicinePapaverinemedicineAnimalsBenzylisoquinolinesPharmacologyPapaverineEstradiolChemistryMuscle SmoothRats Inbred StrainsCalcium Channel BlockersIsoquinolinesGlaucineRatsEndocrinologyPotassiumCalciumFemalemedicine.symptomMuscle contractionmedicine.drugMuscle ContractionThe Journal of pharmacy and pharmacology
researchProduct